1. Identification of group B streptococcal Sip protein, which elicits cross-protective immunity.
- Author
-
Brodeur BR, Boyer M, Charlebois I, Hamel J, Couture F, Rioux CR, and Martin D
- Subjects
- Amino Acid Sequence, Animals, Antibodies, Antibodies, Monoclonal biosynthesis, Antibodies, Monoclonal immunology, Antigens, Bacterial chemistry, Bacterial Vaccines genetics, Cloning, Molecular, Cross Reactions, Female, Genes, Bacterial, Mice, Mice, Inbred BALB C, Molecular Sequence Data, Sequence Analysis, DNA, Streptococcus agalactiae classification, Vaccination, Vaccines, Synthetic genetics, Vaccines, Synthetic immunology, Antigens, Bacterial immunology, Bacterial Vaccines immunology, Streptococcal Infections prevention & control, Streptococcus agalactiae immunology
- Abstract
A protein of group B streptococci (GBS), named Sip for surface immunogenic protein, which is distinct from previously described surface proteins, was identified after immunological screening of a genomic library. Immunoblots using a Sip-specific monoclonal antibody indicated that a protein band with an approximate molecular mass of 53 kDa which did not vary in size was present in every GBS strain tested. Representatives of all nine GBS serotypes were included in the panel of strains. Cloning and sequencing of the sip gene revealed an open reading frame of 1,305 nucleotides coding for a polypeptide of 434 amino acid residues, with a calculated pI of 6. 84 and molecular mass of 45.5 kDa. Comparison of the nucleotide sequences from six different strains confirmed with 98% identity that the sip gene is highly conserved among GBS isolates. N-terminal amino acid sequencing also indicated the presence of a 25-amino-acid signal peptide which is cleaved in the mature protein. More importantly, immunization with the recombinant Sip protein efficiently protected CD-1 mice against deadly challenges with six GBS strains of serotypes Ia/c, Ib, II/R, III, V, and VI. The data presented in this study suggest that this highly conserved protein induces cross-protective immunity against GBS infections and emphasize its potential as a universal vaccine candidate.
- Published
- 2000
- Full Text
- View/download PDF